[帕金森病] 这是什么?
Manabu Funayama1, Yoshiaki Furukawa
1Research Institute for Diseased of Old Age, Graduate School of Medicine, Juntendo University.
Brain and nerve = Shinkei kenkyu no shinpo
|May 12, 2025
概括
在帕金森病中进行遗传研究.
科学领域:
- 神经遗传学 神经遗传学
- 帕金森病病理生理病理学
背景情况:
- 大多数帕金森病 (PD) 病例是零星的,但在一些家庭中发生家族聚合.
- 鉴定致病基因已经推进了PD诊断和治疗.
- 了解基因功能和病理生理学对于PD研究至关重要.
研究的目的:
- 审查帕金森病遗传学的历史和最近的发现.
- 为在日本提供针对家族性和零星性PD的基因检测提供指导.
主要方法:
- 对帕金森病历史遗传研究的审查.
- 分析PD遗传学当前的尖端研究成果.
- 讨论不同PD类型的基因测试策略.
主要成果:
- 在识别与PD相关的基因方面取得了重大进展.
- 基因检测协议正在随着新发现而发展.
- 了解遗传贡献有助于个性化的PD管理.
结论:
- 基因洞察力对于理解和管理帕金森病至关重要.
- 针对性基因检测方法对于日本的家族性和零星性PD病例至关重要.
相关概念视频
Parkinson's Disease: Overview
319
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
319
Parkinson's Disease: Treatment
154
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
154
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Alzheimer's Disease: Overview
323
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
323
REM Sleep Behavior Disorder
113
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
113


